Biosimilar - PDFSEARCH.IO - Document Search Engine

Biosimilar
Results: 639

#	Item
581	European Commission Counterfeit Medicines for Human Use Consultation B232[removed]B-1049 Brussels Belgium Add to Reading List Source URL: ec.europa.eu Language: English - Date: 2013-10-09 09:03:02 Medicine Pharmaceutical industry Biotechnology Pharmacy Pharmaceuticals policy Biosimilar EuropaBio Biologic Counterfeit medications Pharmaceutical sciences Pharmacology Health
582	Ref. Ares[removed][removed]EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Tourism, CSR, Consumer Goods and International Regulatory Agreements Food and Healthcare Industries, Biotechnology Add to Reading List Source URL: ec.europa.eu Language: English - Date: 2012-10-18 12:54:08 Biosimilar Biotechnology Drugs
583	Microsoft PowerPoint - Presentation on biosimilars under Tajani initiative FINAL Add to Reading List Source URL: www.europabio.org Language: English - Date: 2014-06-30 08:09:50 European Federation of Pharmaceutical Industries and Associations Biosimilar Biotechnology Drugs
584	Microsoft Word - EuropaBio QA on biosimilars under Tajani's Initiative FINAL Add to Reading List Source URL: www.europabio.org Language: English - Date: 2014-06-30 08:10:07 Clinical research Biosimilar Biotechnology Drugs Biologic Pharmacovigilance European Federation of Pharmaceutical Industries and Associations Pharmaceutical industry Antonio Tajani Pharmacology Pharmaceutical sciences Pharmacy
585	What you Need to Know about Biosimilar Medicinal Products Add to Reading List Source URL: ec.europa.eu Language: English - Date: 2013-04-22 02:55:35 Pharmaceuticals policy Clinical research Pharmaceutical industry Biotechnology European Medicines Agency Biosimilar Biologic Pharmacovigilance EudraLex Pharmaceutical sciences Pharmacology Health
586	Microsoft Word - EuropaBio Briefing Paper on biosimilars under Tajani's Initiative FINAL Add to Reading List Source URL: www.europabio.org Language: English - Date: 2014-06-30 08:10:01 Pharmaceutical industry Pharmacy Pharmaceuticals policy Biosimilar Drugs Biologic European Federation of Pharmaceutical Industries and Associations Pharmacovigilance Good manufacturing practice Pharmaceutical sciences Pharmacology Medicine
587	Generic Versions of Biologics: The Problem and a Possible Solution By Paul F. Prestia This article is reprinted with permission from The Legal Intelligencer. © 2008 ALM Properties Inc. Further duplication without permis Add to Reading List Source URL: www.ipo.org Language: English - Date: 2013-03-31 19:00:47 Pharmaceuticals policy Pharmaceutical industry Biosimilar Biotechnology Drugs Biologic Drug Price Competition and Patent Term Restoration Act Generic drug Abbreviated New Drug Application Pharmaceutical sciences Pharmacology Clinical research
588	\\server05\productn\B\BLC\2-1\BLC111.txt unknown Seq: 1 Add to Reading List Source URL: www.ipo.org Language: English - Date: 2013-03-31 20:58:48 Clinical research Biotechnology Pharmaceuticals policy Drugs Biosimilar Abbreviated New Drug Application Biopharmaceutical Generic drug Drug Price Competition and Patent Term Restoration Act Pharmaceutical sciences Pharmacology Pharmaceutical industry
589	biosimilars trial timeline Analyze clinical trials of generic manufacturers to assess the competitive trial landscape and predict potential biosimilar launch timing. Add to Reading List Source URL: www.bizcharts.com Language: English - Date: 2013-09-16 15:30:07 Science Design of experiments Clinical trials Pharmacology Biosimilar ClinicalTrials.gov Research Clinical research Pharmaceutical industry
590	EU/US administrative simplification Workshop Add to Reading List Source URL: ec.europa.eu Language: English - Date: 2012-10-18 12:53:39 Pharmaceutical industry European Medicines Agency Food and Drug Administration Biosimilar Common Technical Document Good Laboratory Practice Validation Pharmaceutical sciences Pharmacology Clinical research

UPDATE